Atlas Trials

Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

Clinical trial NCT07671508 · COMPLETED

Trial details

NCT number
NCT07671508
Sponsor
MIPO Clinic
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Malignant NeoplasmsTuberculosis (TB)HEPATITIS C (HCV)
Start date
2013-05-15
Primary completion
2013-09-21
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.